[Featured Stocks] Sewoon Medical, Lapas, Seorin Bio and Other Vaccine-Related Stocks Rise on Government Moderna and Pfizer Vaccine Imports

[Asia Economy Reporter Minwoo Lee] Shares of vaccine-related stocks such as Sewoon Medical, Lapas, and Seorin Bio are showing strong performance. This reflects expectations that they will benefit from the government's announcement of importing COVID-19 vaccines from U.S. pharmaceutical companies Moderna and Pfizer.

As of 11:04 a.m. on the 8th, Sewoon Medical's stock price traded at 7,850 KRW, up 25.36% compared to the previous day. Lapas and Seorin Bio also rose by 9.03% and 5.14%, respectively, at the same time. Their commonality is that they are engaged in businesses related to vaccine administration.

Sewoon Medical manufactures consumable medical devices such as medical suction devices, catheters for urinary drainage, orthopedic use, and pharmaceutical infusion. Lapas, established in 2006, developed the 'DEN' production technology capable of mass-producing microneedles and has produced the largest number of microneedles worldwide. Microneedles are expected to be able to store and transport Moderna and Pfizer vaccines, which require ultra-low temperature storage between -20 to -70 degrees Celsius. Seorin Bio also supplies products related to cold chain transportation.

Meanwhile, the government reviewed and approved a plan to increase the procurement of COVID-19 vaccines from the initially planned 30 million doses to 44 million doses at the Cabinet meeting chaired by the Prime Minister on the same day, and discussed vaccination measures. It was reported that a pre-purchase contract for 20 million doses was completed with the global vaccine company AstraZeneca, and contracts for pre-purchasing 20 million doses each with Pfizer and Moderna, and 4 million doses with Janssen are currently underway.

This content was produced with the assistance of AI translation services.